We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Uber
UBER
$147B
| $13.6M | 0.03% |
314,485
+248,513
| +377% | +$9.24M |
|
477
Popular Inc
BPOP
$10.5B
| $13.5M | 0.03% |
223,275
-4,695
| -2% | -$277K |
|
|
APLS
478
DELISTED
Apellis Pharmaceuticals
APLS
| $13.4M | 0.03% |
147,465
-363,837
| -71% | -$31.4M |
|
479
HCA Healthcare
HCA
$91.8B
| $13.4M | 0.03% |
44,216
+27,302
| +161% | +$7.59M |
|
480
MongoDB
MDB
$30.5B
| $13.3M | 0.03% |
+32,473
| New | +$9.47M |
|
481
Yum! Brands
YUM
$38.6B
| $13.2M | 0.03% |
95,557
+52,917
| +124% | +$7.17M |
|
482
Synopsys
SNPS
$70.1B
| $13.2M | 0.03% |
30,400
-47,027
| -61% | -$18.9M |
|
483
Commercial Metals
CMC
$7.21B
| $13.2M | 0.03% |
251,126
+48,245
| +24% | +$2.25M |
|
|
MODN
484
DELISTED
MODEL N, INC.
MODN
| $13.2M | 0.03% |
372,283
-9,093
| -2% | -$292K |
|
485
SL Green Realty
SLG
$3.71B
| $13.1M | 0.03% |
437,563
-144,123
| -25% | -$3.48M |
|
486
Rezolute
RZLT
$399M
| $13.1M | 0.03% |
6,610,274
| – | – |
|
|
NAPA
487
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $13M | 0.03% |
1,000,000
-200,000
| -17% | -$2.84M |
|
488
Alcon
ALC
$32.8B
| $12.8M | 0.03% |
156,360
| – | – |
|
489
Novartis
NVS
$264B
| $12.8M | 0.03% |
126,686
-16,220
| -11% | -$1.62M |
|
490
FTI Consulting
FCN
$4.12B
| $12.8M | 0.03% |
67,138
+62,001
| +1,207% | +$11.7M |
|
|
CWEN.A
491
DELISTED
Clearway Energy Class A
CWEN.A
| $12.7M | 0.03% |
471,073
+66,863
| +17% | +$1.94M |
|
|
WBS
492
DELISTED
Webster Financial
WBS
| $12.7M | 0.03% |
335,906
-10,088
| -3% | -$372K |
|
493
Nucor
NUE
$58.8B
| $12.7M | 0.03% |
77,198
-4,211
| -5% | -$615K |
|
494
Baxter International
BAX
$12.3B
| $12.6M | 0.03% |
276,622
+207,122
| +298% | +$9.02M |
|
495
W.W. Grainger
GWW
$60.1B
| $12.6M | 0.03% |
15,974
+45
| +0.3% | +$31K |
|
|
XYZ
496
Block Inc
XYZ
$47.5B
| $12.5M | 0.03% |
188,392
+40,866
| +28% | +$2.55M |
|
497
Avantor
AVTR
$10.6B
| $12.3M | 0.03% |
601,115
-96,884
| -14% | -$1.96M |
|
498
Azenta
AZTA
$1.46B
| $12.3M | 0.03% |
264,066
-12,920
| -5% | -$566K |
|
499
KB Home
KBH
$3.04B
| $12.3M | 0.03% |
237,009
-218,157
| -48% | -$9.84M |
|
500
White Mountains Insurance
WTM
$4.86B
| $12.2M | 0.03% |
8,800
-122
| -1% | -$172K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.